# Transcatheter Arterial Chemoembolization With KMG Microsphere Treating Advance-stage Hepatocellular Carinomas (TACE-KMG)

> **NCT01393197** · NA · UNKNOWN · sponsor: **Tianjin Medical University Cancer Institute and Hospital** · enrollment: 2480 (estimated)

## Conditions studied

- Carcinoma, Hepatocellular

## Interventions

- **OTHER:** Therapeutic Chemoembolization

## Key facts

- **NCT ID:** NCT01393197
- **Lead sponsor:** Tianjin Medical University Cancer Institute and Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-03
- **Primary completion:** 2016-11
- **Final completion:** 2016-12
- **Target enrollment:** 2480 (ESTIMATED)
- **Last updated:** 2015-12-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01393197

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01393197, "Transcatheter Arterial Chemoembolization With KMG Microsphere Treating Advance-stage Hepatocellular Carinomas (TACE-KMG)". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT01393197. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*